Serko announces a capital raise; Tesla’s $1.06 billion investment; CVS, Walgreens and Walmart linked to opioid crisis.

Recap

English - November 24, 2021 04:13 - 10 minutes - 14.7 MB - ★★★★★ - 2 ratings
Investing Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Zoom unmutes expectations with its Q3 results; Arvida profits increase despite pandemic woes; TradeWindow lists on the NZX.

Next Episode: Fisher & Paykel Healthcare beats forecasts; Westpac NZ board “falls short”; The supply chain hits Gap right in the sales.

The latest Serko (SKO) results see a profit loss, but only due to planned spending. A federal jury finds CVS Health (CVS), Walgreens (WBA) and Walmart (WMT) had a role to play in America’s opioid crisis. Tesla (TSLA) primed to make a $1.06 billion dollar investment in it’s latest gigafactory.

www.sharesies.com

For more share market news, subscribe to Lunch Money, Sharesies’ bite-sized email update: https://www.sharesies.nz/lunch-money

Lunch Money: TradeWindow's direct-listing on the NZX with COO Andrew Balgarnie

If you'd like to get in touch, for any reason at all, email [email protected] or record a voice message: https://anchor.fm/sharesies2/message.

Investing involves risk. You aren’t guaranteed to make money, and you might lose the money you start with. We don’t provide personalised advice or recommendations. Any information we provide is general only and current at the time. For specific advice, speak to a licensed financial advice provider